Mr. Thomas Looby reports
CONAVI MEDICAL ANNOUNCES FIVE-YEAR EXTENSION OF CREDIT FACILITIES WITH JAPAN LIFELINE
Conavi Medical Corp. has entered into an amendment with Japan Lifeline Co., Ltd. extending the maturity of the company's existing senior secured credit facilities by five years, from April, 2027 to April, 2032.
The extension better aligns Conavi's debt maturity profile with its commercial development plans following FDA 510(k) clearance and the completion of its first U.S. commercial placement and clinical cases with the OCTIV hybrid imaging system.
"Japan Lifeline has supported Conavi for more than a decade, and we appreciate its continued commitment as we advance commercialization," said Thomas Looby, president and chief executive officer of Conavi Medical. "This extension gives us greater financial flexibility to build on our initial U.S. clinical and commercial milestones."
The interest rate under the credit facilities will increase from 6.5 per cent to 10 per cent per annum; however, consistent with the existing terms of the credit facilities, Conavi is generally not required to make any interest payments until maturity.
Additional details regarding the amendment will be included in the company's regulatory filings on SEDAR+.
About Conavi Medical Corp.
Conavi Medical is a commercial-stage medical device company focused on designing, manufacturing and marketing imaging technologies to guide minimally invasive cardiovascular procedures.
We seek Safe Harbor.
© 2026 Canjex Publishing Ltd. All rights reserved.